Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2008

Open Access 01-12-2008 | Case report

Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report

Authors: Kolitha Basnayake, Colin Hutchison, Dia Kamel, Michael Sheaff, Neil Ashman, Mark Cook, Heather Oakervee, Arthur Bradwell, Paul Cockwell

Published in: Journal of Medical Case Reports | Issue 1/2008

Login to get access

Abstract

Introduction

Acute renal failure in multiple myeloma is most frequently caused by cast nephropathy, when excess monoclonal free light chains co-precipitate with Tamm-Horsfall protein in the distal nephron, causing tubular obstruction. The natural history of cast nephropathy after diagnosis is unknown. This report provides supporting histological evidence that, as serum free light chain concentrations fall, intratubular casts may resolve within weeks.

Case presentation

We report the case of a 61-year-old Caucasian woman who presented with multiple myeloma and dialysis-dependent acute renal failure, with serum kappa free light chain concentrations of 15,700 mg/litre (normal range 3.3 to 19.4 mg/litre). Renal biopsy demonstrated cast nephropathy with waxy casts in distal tubules and collecting ducts. There was an interstitial inflammatory cell infiltrate with diffuse fibrosis and tubular atrophy. Following rehydration, chemotherapy and free light chain removal using high cut-off haemodialysis, free light chain concentrations fell to less than 5% of the starting level (500 mg/litre). A repeat renal biopsy 6 weeks after the first showed resolution of cast nephropathy.

Conclusion

These observations indicate that cast nephropathy can quickly resolve on rapid reduction of monoclonal serum free light chains. This has important implications for the development of treatment strategies aimed at improving renal recovery rates for patients in this setting.
Appendix
Available only for authorised users
Literature
1.
go back to reference Knudsen LM, Hjorth M, Hippe E, Knudsen LM, Hjorth M, Hippe E: Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Haematol. 2000, 65: 175-181. 10.1034/j.1600-0609.2000.90221.x.CrossRefPubMed Knudsen LM, Hjorth M, Hippe E, Knudsen LM, Hjorth M, Hippe E: Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Haematol. 2000, 65: 175-181. 10.1034/j.1600-0609.2000.90221.x.CrossRefPubMed
2.
go back to reference Torra R, Blade J, Cases A, Lopez-Pedret J, Montserrat E, Rozman C, Revert L: Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases. Br J Haematol. 1995, 91: 854-859. 10.1111/j.1365-2141.1995.tb05400.x.CrossRefPubMed Torra R, Blade J, Cases A, Lopez-Pedret J, Montserrat E, Rozman C, Revert L: Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases. Br J Haematol. 1995, 91: 854-859. 10.1111/j.1365-2141.1995.tb05400.x.CrossRefPubMed
3.
go back to reference Herrera GA, Joseph L, Gu X, Hough A, Barlogie B: Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med. 2004, 128: 875-879.PubMed Herrera GA, Joseph L, Gu X, Hough A, Barlogie B: Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med. 2004, 128: 875-879.PubMed
4.
go back to reference Sanders PW, Booker BB, Bishop JB, Cheung HC: Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins. J Clin Invest. 1990, 85: 570-576. 10.1172/JCI114474.CrossRefPubMedPubMedCentral Sanders PW, Booker BB, Bishop JB, Cheung HC: Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins. J Clin Invest. 1990, 85: 570-576. 10.1172/JCI114474.CrossRefPubMedPubMedCentral
6.
go back to reference Rose PE, McGonigle R, Michael J, Boughton BJ: Renal failure and the histopathological features of myeloma kidney reversed by intensive chemotherapy and peritoneal dialysis. Br Med J (Clin Res Ed). 1987, 294: 411-412.CrossRef Rose PE, McGonigle R, Michael J, Boughton BJ: Renal failure and the histopathological features of myeloma kidney reversed by intensive chemotherapy and peritoneal dialysis. Br Med J (Clin Res Ed). 1987, 294: 411-412.CrossRef
7.
go back to reference Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M: Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Nephrol. 2007, 18: 886-895. 10.1681/ASN.2006080821.CrossRefPubMed Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M: Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Nephrol. 2007, 18: 886-895. 10.1681/ASN.2006080821.CrossRefPubMed
8.
go back to reference Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, Drew R: Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem. 2001, 47: 673-680.PubMed Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, Drew R: Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem. 2001, 47: 673-680.PubMed
9.
go back to reference Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA: Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002, 48: 1437-1444.PubMed Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA: Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002, 48: 1437-1444.PubMed
10.
go back to reference Cheson BD, De Bellis CC, Schumann GB, Schumann JL, Cheson BD, De Bellis CC, Schumann GB, Schumann JL: The urinary myeloma cast. Frequency of detection and clinical correlations in 30 patients with multiple myeloma. Am J Clin Pathol. 1985, 83: 421-425.CrossRefPubMed Cheson BD, De Bellis CC, Schumann GB, Schumann JL, Cheson BD, De Bellis CC, Schumann GB, Schumann JL: The urinary myeloma cast. Frequency of detection and clinical correlations in 30 patients with multiple myeloma. Am J Clin Pathol. 1985, 83: 421-425.CrossRefPubMed
11.
go back to reference Pote A, Zwizinski C, Simon EE, Meleg-Smith S, Batuman V: Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells. Am J Kidney Dis. 2000, 36: 735-744. 10.1053/ajkd.2000.17620.CrossRefPubMed Pote A, Zwizinski C, Simon EE, Meleg-Smith S, Batuman V: Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells. Am J Kidney Dis. 2000, 36: 735-744. 10.1053/ajkd.2000.17620.CrossRefPubMed
12.
go back to reference Li M, Hering-Smith KS, Simon EE, Batuman V: Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol Dial Transplant. 2008, 23: 860-870. 10.1093/ndt/gfm670.CrossRefPubMed Li M, Hering-Smith KS, Simon EE, Batuman V: Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol Dial Transplant. 2008, 23: 860-870. 10.1093/ndt/gfm670.CrossRefPubMed
13.
go back to reference Wang PX, Sanders PW: Immunoglobulin light chains generate hydrogen peroxide. J Am Soc Nephrol. 2007, 18: 1239-1245. 10.1681/ASN.2006111299.CrossRefPubMed Wang PX, Sanders PW: Immunoglobulin light chains generate hydrogen peroxide. J Am Soc Nephrol. 2007, 18: 1239-1245. 10.1681/ASN.2006111299.CrossRefPubMed
14.
go back to reference Sanders PW, Herrera GA, Chen A, Booker BB, Galla JH: Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo. J Clin Invest. 1988, 82: 2086-2096. 10.1172/JCI113830.CrossRefPubMedPubMedCentral Sanders PW, Herrera GA, Chen A, Booker BB, Galla JH: Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo. J Clin Invest. 1988, 82: 2086-2096. 10.1172/JCI113830.CrossRefPubMedPubMedCentral
15.
go back to reference Farrington K, Udayaraj U, Gilg J, Feest T, Feehally J: New adult patients starting renal replacement therapy in the UK in 2006. UK Renal Registry Tenth Annual Report. Edited by: Ansell D, Feehally J, Feest T, Tomson C, Williams AJ, Warwick G. 2007, Bristol, UK: UK Renal Registry, 17-47. Farrington K, Udayaraj U, Gilg J, Feest T, Feehally J: New adult patients starting renal replacement therapy in the UK in 2006. UK Renal Registry Tenth Annual Report. Edited by: Ansell D, Feehally J, Feest T, Tomson C, Williams AJ, Warwick G. 2007, Bristol, UK: UK Renal Registry, 17-47.
Metadata
Title
Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report
Authors
Kolitha Basnayake
Colin Hutchison
Dia Kamel
Michael Sheaff
Neil Ashman
Mark Cook
Heather Oakervee
Arthur Bradwell
Paul Cockwell
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2008
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-2-380

Other articles of this Issue 1/2008

Journal of Medical Case Reports 1/2008 Go to the issue